Surrozen, Inc.
NASDAQ:SRZN
Overview | Financials
Company Name | Surrozen, Inc. |
Symbol | SRZN |
Currency | USD |
Price | 12.81 |
Market Cap | 41,629,938 |
Dividend Yield | 0% |
52-week-range | 6 - 18.17 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Craig C. Parker M.B.A. |
Website | https://www.surrozen.com |
An error occurred while fetching data.
About Surrozen, Inc.
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD